Search
Close this search box.
Register
Healthed-White-on-Blue
Search
Close this search box.
Grohmann, Gary

Dr Gary Grohmann

Virologist; Consultant, World Health Organisation; Board Member, Immunisation Coalition; Former Director, Immunobiology at the TGA; Adjunct Professor, Faculty of Medicine, University of Sydney
Dr. Gary Grohmann B. Sc. (Hons), PhD, FASM Gary Grohmann is former Director of Immunobiology and WHO ERL at the TGA, Office of Laboratories and Scientific services from 1997-2015. He currently works as an independent consultant, primarily with the WHO on influenza related projects in the Global Influenza Programme and the Essential Medicines Programme.

Dr. Grohmann has served on several WHO steering committees including the committee for the review of the IVTM database on influenza viruses and reassortant influenza viruses, and the WHO VCM committee that recommends virus strains for influenza vaccines (until 2015). He has also been a member of the Technical Advisory Group (2007-2015) of the Global Action Plan for Influenza.

His primary interests are in vaccines, vaccine regulation, medical and veterinary virology, and infectious diseases resulting from contaminated food and water as well as other environmental sources. Dr. Grohmann is currently a Board Member of the Immunisation Coalition and Adjunct Professor at the University of Sydney.

More from this expert

coronavirus-4914028_1920
Podcasts iconPodcasts

Long COVID update

Listen to the latest on Long COVID, with Dr Gary Grohmann, where we address the important considerations for Long COVID, what we know now, and how to treat, prevent and reduce the severity of Long COVID.

Shanghai,,China,-,May,10,2022:,Shanghai,Enters,The,Second
Podcasts iconPodcasts

COVID Update

Antiviral drugs and other therapeutics, new drugs and vaccines in the pipeline. Are universal vaccines a pipe dream? Why vaccines are only part of the answer and will never control the pandemic?

shutterstock_1809207769

Omicron update – Cause for optimism?

By Dr Gary Grohmann
Podcasts iconPodcasts
Coronavirus,And,Dna,Strands,-,Medical,3d,Illustration

Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

Transitioning our patients to Novavax and protein-based vaccines and away from mRNA. Monkeypox should be taken seriously... especially for high-risk patients

By Dr Gary Grohmann
Podcasts iconPodcasts
Shanghai,,China,-,May,10,2022:,Shanghai,Enters,The,Second

COVID Update

Antiviral drugs and other therapeutics, new drugs and vaccines in the pipeline. Are universal vaccines a pipe dream? Why vaccines are only part of the answer and will never control the pandemic?

By Dr Gary Grohmann
Podcasts iconPodcasts
Coronavirus,And,Dna,Strands,-,Medical,3d,Illustration

COVID update – 5th booster, mRNA-based vaccines and 2023 forecast

The pros and cons of a 5th jab for health workers, whether we have reached the end of the road with mRNA-based vaccines, cutting through the subvariant hype, new vaccines on the horizon, and the 2023 forecast - does ATAGI need a rethink?

By Dr Gary Grohmann
Podcasts iconPodcasts
Woman,With,Face,Mask,Getting,Vaccinated,,Coronavirus,,Covid-19,And,Vaccination

COVID Update – A national CDC, boosters for young people and China’s response to the surge

How healthy young people will derive little benefit from a fourth or fifth dose of vaccine, and how we should keep them for the vulnerable population, and China's response to the COVID surge being of global interest and concern

By Dr Gary Grohmann
Podcasts iconPodcasts
chinesenewyear

Trouble in China: Might Omicron become Omega?

A massive surge in Omicron infections in China likely means new subvariants—and potentially worse.

By Prof Robert Booy, Dr Gary Grohmann
Clinical Articles iconClinical Articles
Woman,Showing,Plaster,After,Receiving,Covid,19,Vaccine.,Vaccination,,Herd

COVID update – Which booster and for who?

Zinc, Selenium, Melatonin, and Vitamin D supplements are useful adjuncts in the early stages of COVID-19 infection

By Dr Gary Grohmann
Podcasts iconPodcasts
pexels-thirdman-5921833-scaled

COVID-19 boosters: Should we all line up for a 4th or 5th dose?

Dr Gary Grohmann and Prof Robert Booy weigh up the research on boosters

By Dr Gary Grohmann, Prof Robert Booy
Clinical Articles iconClinical Articles
Coronavirus,Covid-19,Pandemic,Crisis,In,Tokyo,Japan.japanese,Mother,With,Kids

COVID update – Booster confusion, the origin debate, downside of RATs

Are the bivalent vaccines what they are cracked up to be? Plus the origin of COVID-19

By Dr Gary Grohmann
Podcasts iconPodcasts
A,Young,Girl,In,The,Background,Of,A,Building,Wears

COVID update – It’s not over, vaccine risk/benefit, masks, long COVID

How do we tell the public it is not over? Are mask beneficial? How to justify the use of vaccines that can cause serious adverse reactions in healthy people.

By Dr Gary Grohmann
Podcasts iconPodcasts
An,African,Doctor,Holding,A,Covid,19,Vaccine,Vial,In

COVID update – Vaccine and variant update

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

By Dr Gary Grohmann
Podcasts iconPodcasts
Covid-19,Vaccine,,Doctor,Man,Pull,Syringe,On,Liquid,Bottle,Covid-19

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

By Dr Gary Grohmann
Podcasts iconPodcasts

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform